Finding 957347 (2021-006)

Material Weakness
Requirement
ABL
Questioned Costs
-
Year
2021
Accepted
2024-03-18

AI Summary

  • Core Issue: The Hospital reported expenditures not incurred during the correct period, violating compliance requirements.
  • Impacted Requirements: Internal controls over federal awards were inadequate, failing to ensure proper reporting and review processes.
  • Recommended Follow-Up: Implement a robust internal control policy to ensure expenditures are accurately reported in the correct periods.

Finding Text

Department of Health and Human Services Federal Assistance Listing/CFDA #93.498 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 1 TIN #730929722 Activities Allowed or Unallowed, Allowable Costs/Cost Principles, and Reporting Material Weakness in Internal Control Over Compliance and Noncompliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition: The Hospital claimed expenditures that were not incurred during the reporting period. These expenditures were identified as unallowed on the Hospital’s schedule of expenditures, but inadvertently included in the amounts ultimately reported on the Period 1 report to HHS. Cause: The Hospital did not have an adequate internal control process in place to ensure expenditures claimed were being in the proper period. The Hospital also did not have a control to ensure the reporting was reviewed and approved by someone other than the preparer. Effect: The Hospital claimed and reported expenditures in the incorrect reporting period. Questioned Costs: None. While there were $240,637 of expenditures considered to be reported in the incorrect reporting period, the Hospital had excess lost revenues of $268,046 and additional underreported lost revenues of $459,421, which covers the error. Context: We sampled 60 of 382 expenditure transactions. We noted five selections resulting in a specific error totaling $240,637. Upon discovery of the error, we reviewed all purchase dates of expenditures to ensure no additional expenditures were outside the reporting period. Repeat Finding from Prior Years: No Recommendation: We recommend the Hospital create an internal control policy to ensure expenditures are reported in the correct period. Views of Responsible Officials: Management agrees with the finding.

Categories

Allowable Costs / Cost Principles Reporting Procurement, Suspension & Debarment Material Weakness

Other Findings in this Audit

  • 380904 2021-005
    Material Weakness
  • 380905 2021-006
    Material Weakness
  • 380906 2021-007
    Material Weakness
  • 380907 2021-008
    Material Weakness
  • 380908 2021-009
    Material Weakness
  • 957346 2021-005
    Material Weakness
  • 957348 2021-007
    Material Weakness
  • 957349 2021-008
    Material Weakness
  • 957350 2021-009
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $3.95M
93.301 Small Rural Hospital Improvement Grant Program $78,499
93.889 National Bioterrorism Hospital Preparedness Program $12,190